Brind.

On August 13, 2025, the Price-to-Earnings ratio of Incepta Pharmaceuticals was noted to match that of Cardinal Health.

1 report, 1 independent Updated Aug 13

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Incepta Pharmaceuticals Cardinal Health

Keep exploring

The entities involved

Incepta Pharmaceuticals
incepta
- Tilray Brands, Inc.'s stock change lagged the S&P 500 gain on August 28, 2025, while the company holds a Zacks Rank of #3.Sun 03:24
- Precision BioSciences and Incepta Pharmaceuticals were noted as belonging to a specified industry in August 2025.Sat 20:39
Cardinal Health
Healthcare company
- Morgan Stanley raised its price target for Cardinal Health on August 8, 2025.Sun 07:34
- Trump's pledge to unleash oil and gas benefits certain stocks.Sun 02:30

Coverage

Newest first; wire copies grouped

Aug 13ZacksAre You a Value Investor? This 1 Stock Could Be the Perfect Pick For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Achieving those g